E3	Condition:T3 Name:T4
E5	Condition:T5 Name:T6 Stability:T1 Duration:E1
E8	Procedure:T8 Name:T9
E10	Procedure:T10 Name:T11
E1	Eq-Comparison:T2 Operator:T21 Temporal-Unit:T18 Value:T19
E2	Coreference:T7 Refers-To:E5
E4	Condition:T25 Severity:T22
E6	Indication:T26 Indication-For:E10
E9	Or:T27 Arg:E10 Arg2:E8
E11	Condition:T12 Name:T13
E12	Condition:T14 Name:T15
E13	Condition:T16 Name:T17
E14	Or:T28 Arg:E12 Arg2:E13
E15	Condition:T29 Name:T30
E16	Modifier:T31 Modifies:T30
E17	Modifier:T32 Modifies:T30
E18	Modifier:T33 Modifies:T30
E19	Or:T34 Arg:E17 Arg2:E16
E20	Study:T35
E21	Study:T36
E22	Or:T37 Arg:E20 Arg2:E21
E23	Temporal-Connection:T38 Arg:E15 Arg2:E20
E24	Condition:T39 Name:T40 Temporality:E25 Temporality2:E27
E25	Eq-Comparison:T41 Temporal-Period:T42
E26	Drug:T20 Name:T43 Temporality:E28
E27	Eq-Comparison:T44 Temporal-Period:T45
E28	Eq-Comparison:T46 Temporal-Period:T47
E7	Eq-Comparison:T24 Value:T23 Value2:T22 Operator:T48
T3	Condition 164 180	plaque psoriasis
T4	Condition-Name 164 180	plaque psoriasis
T5	Condition 192 208	plaque psoriasis
T6	Condition-Name 192 208	plaque psoriasis
T8	Procedure 297 313	systemic therapy
T9	Procedure-Name 297 313	systemic therapy
T10	Procedure 281 293	phototherapy
T11	Procedure-Name 281 293	phototherapy
T18	Eq-Temporal-Unit 224 230	months
T19	Eq-Value 222 223	6
T1	Stability 185 191	Stable
T2	Eq-Comparison 213 230	at least 6 months
T21	Eq-Operator 213 221	at least
T7	Coreference 254 261	disease
T22	Severity 247 253	severe
T23	Severity 235 243	Moderate
T25	Condition 254 261	disease
T26	Indication 267 276	Candidate
T27	Or 294 296	or
T12	Condition 390 409	psoriatic arthritis
T13	Condition-Name 390 409	psoriatic arthritis
T14	Condition 411 434	erythrodermic psoriasis
T15	Condition-Name 411 434	erythrodermic psoriasis
T16	Condition 439 469	generalized pustular psoriasis
T17	Condition-Name 439 469	generalized pustular psoriasis
T28	Or 436 438	or
T29	Condition 529 538	psoriasis
T30	Condition-Name 529 538	psoriasis
T31	Modifier 516 528	drug-induced
T32	Modifier 504 511	inverse
T33	Modifier 495 502	Guttate
T34	Or 513 515	or
T35	Study 542 551	Screening
T36	Study 555 563	Baseline
T37	Or 552 554	or
T38	Temporal-Connection 539 541	at
T39	Condition 587 596	infection
T40	Condition-Name 587 596	infection
T41	Eq-Comparison 580 586	recent
T42	Eq-Temporal-Period 580 586	recent
T20	Drug 620 630	BMS-986165
T43	Drug-Name 620 630	BMS-986165
T44	Eq-Comparison 569 576	History
T45	Eq-Temporal-Period 569 576	History
T46	Eq-Comparison 602 607	Prior
T47	Eq-Temporal-Period 602 607	Prior
T24	Eq-Comparison 235 253	Moderate to severe
T48	Eq-Operator 244 246	to
A1	Eq-Temporal-Unit-Value T18 month
A2	Stability-Value T1 stable
A3	Eq-Operator-Value T21 GTEQ
A4	Severity-Value T22 severe
A5	Severity-Value T23 severe
A6	Temporal-Connection-Type-Value E23 during
A7	Eq-Temporal-Period-Value T42 recent
A8	Eq-Temporal-Period-Value T45 past
A9	Eq-Temporal-Period-Value T47 past
A10	Eq-Operator-Value T48 BETWEEN